• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤 Rosai-Dorfman 病中 IgG4 和 IgG 的表达评估。

The evaluation of IgG4 and IgG expression in cutaneous Rosai-Dorfman disease.

机构信息

Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, China.

Dermatology Department, Dermatology Hospital, Southern Medical University, Guangzhou, China.

出版信息

An Bras Dermatol. 2023 Sep-Oct;98(5):651-655. doi: 10.1016/j.abd.2022.07.010. Epub 2023 Jun 8.

DOI:10.1016/j.abd.2022.07.010
PMID:37301673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10404508/
Abstract

OBJECTIVE

The authors investigated the expression of IgG4 and IgG in cutaneous Rosai-Dorfman Disease (CRDD) to further improve the understanding of this disease.

METHODS

The authors retrospectively reviewed the clinicopathological features of 23 CRDD patients. The authors diagnosed CRDD by the presence of emperipolesis and immunohistochemical (IHC) staining of histiocytes consisting of S-100(+)/CD68(+)/CD1a(-) cells. The expressions of IgG and IgG4 in cutaneous specimens were assessed by IHC (EnVision) and quantitatively calculated by a medical image analysis system.

RESULTS

All 23 patients, including 14 males and 9 females, were confirmed to have CRDD. Their ages ranged from 17 to 68 years (mean 47.91 ± 14.16). The most frequently affected skin regions were the face, followed by the trunk, ears, neck, limbs, and genitals. In 16 of these cases, the disease presented as a single lesion. IHC staining of sections showed that IgG was positive (≥ 10 cells/High-Power Field [HPF]) in 22 cases, while IgG4 was positive (≥ 10 cells/HPF) in 18 cases. Moreover, the IgG4/IgG proportion ranged from 1.7% to 85.7% (mean 29.50 ± 24.67%, median 18.4%) in the 18 cases.

STUDY LIMITATIONS

In the majority of studies, as well as in the current study, the design. RDD is a rare disease, so the sample size is small. In the next studies to come, the authors will expand the sample for multi-center verification and in-depth study.

CONCLUSION

The positive rates of IgG4 and IgG and the IgG4/IgG ratio assessed through IHC staining may be important in understanding the pathogenesis of CRDD.

摘要

目的

作者研究了 IgG4 和 IgG 在皮肤 Rosai-Dorfman 病(CRDD)中的表达,以进一步了解这种疾病。

方法

作者回顾性分析了 23 例 CRDD 患者的临床病理特征。作者通过存在吞噬现象和组织细胞的免疫组织化学(IHC)染色(由 S-100(+)/CD68(+)/CD1a(-)细胞组成)来诊断 CRDD。通过免疫组织化学(EnVision)评估皮肤标本中 IgG 和 IgG4 的表达,并通过医学图像分析系统定量计算。

结果

23 例患者均确诊为 CRDD,包括 14 例男性和 9 例女性。年龄 1768 岁,平均 47.91±14.16 岁。最常受累的皮肤部位为面部,其次为躯干、耳朵、颈部、四肢和生殖器。在这 16 例病例中,疾病表现为单个病变。切片的 IHC 染色显示,22 例 IgG 阳性(≥ 10 个细胞/高倍视野),18 例 IgG4 阳性(≥ 10 个细胞/高倍视野)。此外,在 18 例病例中,IgG4/IgG 比例为 1.7%85.7%(平均 29.50±24.67%,中位数 18.4%)。

研究局限性

在大多数研究中,以及在当前研究中,设计是回顾性的。RDD 是一种罕见疾病,因此样本量较小。在未来的研究中,作者将扩大样本进行多中心验证和深入研究。

结论

通过 IHC 染色评估 IgG4 和 IgG 的阳性率和 IgG4/IgG 比值可能对了解 CRDD 的发病机制很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c4b/10404508/11b905ea42f5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c4b/10404508/6d205de33fe4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c4b/10404508/7acfda36e50e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c4b/10404508/11b905ea42f5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c4b/10404508/6d205de33fe4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c4b/10404508/7acfda36e50e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c4b/10404508/11b905ea42f5/gr3.jpg

相似文献

1
The evaluation of IgG4 and IgG expression in cutaneous Rosai-Dorfman disease.皮肤 Rosai-Dorfman 病中 IgG4 和 IgG 的表达评估。
An Bras Dermatol. 2023 Sep-Oct;98(5):651-655. doi: 10.1016/j.abd.2022.07.010. Epub 2023 Jun 8.
2
IgG4-positive plasma cells in cutaneous Rosai-Dorfman disease: an additional immunohistochemical feature and possible relationship to IgG4-related sclerosing disease.皮肤型Rosai-Dorfman病中的IgG4阳性浆细胞:一项额外的免疫组化特征及其与IgG4相关硬化性疾病的可能关系
J Cutan Pathol. 2009 Oct;36(10):1069-73. doi: 10.1111/j.1600-0560.2008.01222.x. Epub 2009 Jan 27.
3
Case of Generalized Tumor-Type Rosai-Dorfman Disease With Sarcoidosis-Like Histological Features and IgG4-Positive Plasma Cells.全身性肿瘤型 Rosai-Dorfman 病伴类结节病样组织学特征及 IgG4 阳性浆细胞:病例报告
Am J Dermatopathol. 2021 Jan 1;43(1):e9-e12. doi: 10.1097/DAD.0000000000001724.
4
Rosai-Dorfman Disease of the Breast With Variable IgG4+ Plasma Cells: A Diagnostic Mimicker of Other Malignant and Reactive Entities.乳腺 Rosai-Dorfman 病伴多变 IgG4+浆细胞:一种其他恶性和反应性实体的诊断性类似物。
Am J Surg Pathol. 2019 Dec;43(12):1653-1660. doi: 10.1097/PAS.0000000000001347.
5
[Expression of IgG4 in Rosai-Dorfman disease and its significance].[IgG4在Rosai-Dorfman病中的表达及其意义]
Zhonghua Bing Li Xue Za Zhi. 2015 Oct;44(10):729-33.
6
[Clinicopathologic analysis of extranodal Rosai-Dorfman disease of breast: a report of 12 cases].乳腺结外Rosai-Dorfman病的临床病理分析:附12例报告
Zhonghua Bing Li Xue Za Zhi. 2016 Aug 8;45(8):556-60. doi: 10.3760/cma.j.issn.0529-5807.2016.08.012.
7
Fine-needle aspiration specimens of 3 cases of intra-abdominal Rosai-Dorfman disease with comprehensive review of the literature.3例腹腔内罗萨伊-多夫曼病的细针穿刺标本及文献综述
J Am Soc Cytopathol. 2019 Jul-Aug;8(4):190-205. doi: 10.1016/j.jasc.2019.01.008. Epub 2019 Feb 5.
8
Cutaneous rosai-dorfman disease: a clinical and histopathologic study of 25 cases in China.皮肤型罗萨伊-多夫曼病:中国25例临床及组织病理学研究
Am J Surg Pathol. 2007 Mar;31(3):341-50. doi: 10.1097/01.pas.0000213387.70783.b6.
9
Clinicopathological features of cutaneous Rosai-Dorfman disease and its relationship to IgG4-related disease: a retrospective study.皮肤型罗萨伊-多夫曼病的临床病理特征及其与IgG4相关疾病的关系:一项回顾性研究
Br J Dermatol. 2019 Oct;181(4):844-845. doi: 10.1111/bjd.17939. Epub 2019 Jul 10.
10
Immunoglobulin G4-related chronic rhinosinusitis: a pitfall in the differential diagnosis of granulomatosis with polyangiitis, Rosai-Dorfman disease, and fungal rhinosinusitis.免疫球蛋白 G4 相关慢性鼻-鼻窦炎:在鉴别诊断肉芽肿伴多血管炎、窦组织细胞增生症伴巨大淋巴结病和真菌性鼻-鼻窦炎中的一个陷阱。
Hum Pathol. 2018 Mar;73:82-88. doi: 10.1016/j.humpath.2017.12.011. Epub 2017 Dec 27.

本文引用的文献

1
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.2019 年美国风湿病学会/欧洲抗风湿病联盟 IgG4 相关疾病分类标准。
Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561. Epub 2019 Dec 3.
2
Castleman Disease and Rosai-Dorfman Disease.卡斯特曼病与罗萨伊-多夫曼病。
Semin Diagn Pathol. 2018 Jan;35(1):44-53. doi: 10.1053/j.semdp.2017.11.014. Epub 2017 Dec 2.
3
Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.
罗道尔夫病中相互排斥的 KRAS 和 MAP2K1 突变。
Mod Pathol. 2017 Oct;30(10):1367-1377. doi: 10.1038/modpathol.2017.55. Epub 2017 Jun 30.
4
Review of Rosai-Dorfman Disease: New Insights into the Pathogenesis of This Rare Disorder.罗萨伊-多夫曼病综述:对这种罕见疾病发病机制的新见解
Acta Haematol. 2017;138(1):14-23. doi: 10.1159/000475588. Epub 2017 Jun 15.
5
Cutaneous Rosai-Dorfman Disease of the Face: A Comprehensive Literature Review and Case Report.面部皮肤型罗萨伊-多夫曼病:一项全面的文献综述及病例报告
J Oral Maxillofac Surg. 2016 Mar;74(3):528-40. doi: 10.1016/j.joms.2015.09.017. Epub 2015 Sep 25.
6
A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease?一小部分罗萨伊-多夫曼病病例显示IgG4阳性浆细胞增多:这是另一个干扰因素还是与IgG4相关疾病的真正关联?
Histopathology. 2014 Feb;64(3):455-9. doi: 10.1111/his.12274. Epub 2013 Nov 12.
7
Rosai-Dorfman disease: a case report with nodal and cutaneous involvement and review of the literature.罗萨伊-多夫曼病:一例伴有淋巴结和皮肤受累的病例报告及文献复习
Am J Dermatopathol. 2014 Apr;36(4):353-7. doi: 10.1097/DAD.0b013e31829e5564.
8
A subset of Rosai-Dorfman disease exhibits features of IgG4-related disease.部分罗萨达-多夫曼病表现为 IgG4 相关疾病的特征。
Am J Clin Pathol. 2013 May;139(5):622-32. doi: 10.1309/AJCPARC3YQ0KLIOA.
9
Multicentric reticulohistiocytosis with S100 protein positive staining: a case report.伴有S100蛋白阳性染色的多中心性网状组织细胞增生症:一例报告
Acta Dermatovenerol Croat. 2010;18(1):35-7.
10
Atypical cellular disorders.非典型细胞疾病。
Hematology Am Soc Hematol Educ Program. 2004:283-96. doi: 10.1182/asheducation-2004.1.283.